oncolytic virus therapy (Humane Genomics)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug Nameoncolytic virus therapy (Humane Genomics)
Drug Alias NameHG-001 (Humane Genomics)HGI-627
ClassificationBiologics > Oncolytic virusCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Vesicular stomatitis virus vector
Mechanisms of ActionImmunostimulantsGlypican-3 modulatorsCatenin beta 1 inhibitors
TargetsGlypican-3Catenin beta 1
Therapy Area/IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHumane Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHumane Genomics Inc
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A